Manufacturing and Production

Showing 15 posts of 5866 posts found.

Omontys image

Probe launched as deaths prompt Omontys recall

February 26, 2013 Manufacturing and Production Affymax, Takeda, omontys, recall

Reports of three fatal reactions linked to administration of Takeda and Affymax’ Omontys anaemia treatment have led to a recall …

Pharma manufacturing news in brief

February 26, 2013 Manufacturing and Production Baxter International, Bone Therapeutic, DSM Pharmaceutical Products and Chemtrix, Sovereign Pharmaceutical

Sovereign Pharma rapped by FDA, facility updates from Bone Therapeutics, Baxter and SHL, plus a continuous processing alliance between DSM …
GSK image

Abbott, GSK cut staff at Irish facilities

February 26, 2013 Manufacturing and Production Abbottt, GSK, Ireland

GlaxoSmithKline and Abbott have both announced job cuts at their facilities in Ireland in a blow to the country’s pharmaceutical …

Continuous processing production line set up in Finland

February 25, 2013 Manufacturing and Production Finland, PROMIS

A specialist centre in Finland providing expertise in the continuous processing of pharmaceuticals, first envisaged in 2008, opened its doors …
screen_shot_2013-02-25_at_16

Pharmalink Consulting appoints five consultants

February 25, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmalink Consulting

Regulatory affairs firm Pharmalink Consulting has announced the appointment and promotion of five consultants at their offices in the UK, …
LaMattina image

John LaMattina: Pharma’s reputation continues to suffer – what can be done to fix it?

February 21, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bad pharma, Goldacre, John LaMattina, industry, transparency

You don’t have too look far to find unflattering articles about the pharmaceutical industry. What was previously the domain of …
hakan_bjorklund

Lundbeck elects new chairman

February 21, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lundbeck

Lundbeck has announced it will be electing HÃ¥kan Björklund as its new chairman as Mats Pettersson steps down. Pettersson, a …

SHL to invest 40 Million USD in 2013 to significantly expand production facilities

February 21, 2013 Manufacturing and Production auto injectors, autoinjector, drug delivery, pen injectors

SHL announced plans this week to expand production facilities in Taiwan. A leader in the field of drug delivery devices …
johnny-marshall

NHS Confederation appoints two directors

February 20, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, confederation

The NHS Confederation has announced the appointment of two new directors to the organisation. Dr Johnny Marshall (pictured) and Matt …

Vasella forgoes golden handshake after furore

February 19, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Vasella

Novartis has backed down over plans to pay outgoing chairman Dr Daniel Vasella a ‘golden handshake’ worth $77 million (72 …
GSK image

GSK plans greater use of biocatalysis, continuous processing

February 19, 2013 Manufacturing and Production GSK, Witty, biocatalysis

GlaxoSmithKline says it is turning to technology to help improve the cost efficiency of its manufacturing operations, including greater use …
michel_dubery

inVentiv Health names new European head

February 19, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing inVentic Health

Michel Dubery has been named as the new managing director of inVentiv Health Communications in Europe. Dubery brings more than …

Genzyme’s Waterford plant gets new investment round

February 19, 2013 Manufacturing and Production Genzyme, Sanofi, Waterford

Sanofi’s Genzyme unit plans to spend €44 million on upgrading its plant in Waterford, Ireland, to help meet demand for …
Gilead image

Gilead recalls Vistide on particle contamination

February 19, 2013 Manufacturing and Production Gilead, Vistide

Gilead Sciences has issued a voluntary recall of one lot of its antiviral treatment Vistide after finding particulate matter in …
Takeda HQ image

CMO plant shut down after Takeda product recall

February 19, 2013 Manufacturing and Production CMP, OPG, Takeda

Japan’s regulatory authorities flexed their enforcement muscles last week when it ordered a temporary shutdown of the contract manufacturer for …
The Gateway to Local Adoption Series

Latest content